Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases

Although most classical Hodgkin lymphoma patients are cured, a significant minority fail after primary therapy and may die as result of their disease. To date, there is no consensus on biological markers that add value to usual parameters (which comprise the International Prognostic Score) used at d...

Descripción completa

Detalles Bibliográficos
Autores principales: Canioni, Danielle, Deau-Fischer, Bénédicte, Taupin, Pierre, Ribrag, Vincent, Delarue, Richard, Bosq, Jacques, Rubio, Marie-Thérèse, Roux, Damien, Vasiliu, Viorel, Varet, Bruno, Brousse, Nicole, Hermine, Olivier
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710003/
https://www.ncbi.nlm.nih.gov/pubmed/19623262
http://dx.doi.org/10.1371/journal.pone.0006341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710003/
https://www.ncbi.nlm.nih.gov/pubmed/19623262
http://dx.doi.org/10.1371/journal.pone.0006341

Ejemplares similares